Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.0%

98 terminated/withdrawn out of 1947 trials

Success Rate

91.4%

+4.9% vs industry average

Late-Stage Pipeline

6%

120 trials in Phase 3/4

Results Transparency

0%

3 of 1039 completed trials have results

Key Signals

306 recruiting3 with results58 terminated40 withdrawn

Enrollment Performance

Analytics

N/A
798(78.4%)
Phase 3
87(8.5%)
Phase 2
74(7.3%)
Phase 4
33(3.2%)
Phase 1
25(2.5%)
Early Phase 1
1(0.1%)
1018Total
N/A(798)
Phase 3(87)
Phase 2(74)
Phase 4(33)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1947)

Showing 20 of 1947 trials
NCT00127907Phase 4Completed

Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest

Role: lead

NCT07643454Not Yet Recruiting

Comparison of Trans-Stomial Bladder Lithotripsy Using Mini-Percutaneous Equipment Versus Trans-stomial Bladder Lithotripsy Using Flexible Fibroscope, Percutaneous Approach and Open Cystolithotomy in Patients With Continent Catheterizable Urinary Reservoir

Role: lead

NCT07638111Not ApplicableNot Yet Recruiting

SENSILINS: Impact of Cephalic Phase Insulin Release Induced by an Environmental Food Odor Stimulus on Glucose Homeostasis According to Insulin Sensitivity Level

Role: lead

NCT07630324Not ApplicableNot Yet Recruiting

MEG and Aphantasia

Role: lead

NCT06219135Recruiting

Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis

Role: lead

NCT05089747Recruiting

CIRculating CANcer MAster-Protocol

Role: lead

NCT02810262Completed

Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS)

Role: lead

NCT02392845Phase 1Completed

A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study

Role: lead

NCT06703034Not ApplicableRecruiting

Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19

Role: lead

NCT07637292Active Not Recruiting

Use of Dupilumab in Asthma in Real-world Setting

Role: lead

NCT07636148Not Yet Recruiting

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Role: collaborator

NCT04739202Phase 2Completed

Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST)

Role: lead

NCT06047106Not ApplicableRecruiting

Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.

Role: lead

NCT07634718Not ApplicableNot Yet Recruiting

Implementation Trial In patieNts With rEnal failuRe and diAbetes for Major Adverse reNal and Cardiovascular Events

Role: collaborator

NCT06586138Completed

Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness Test

Role: lead

NCT06016582Not ApplicableCompleted

Use of Virtual Reality Medical Hypnosis for Anxiolytic Purposes During Frozen Embryo Transfer

Role: lead

NCT07623746Not ApplicableNot Yet Recruiting

Neural Mechanisms of Emotion-behaviour Interactions

Role: lead

NCT06484348Not ApplicableRecruiting

Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia

Role: lead

NCT07622095Not Yet Recruiting

Validation of the French Version of the New Mobility Score (NMS)

Role: lead

NCT05923788Not ApplicableCompleted

T1 Mapping in Fabry Disease

Role: lead